Delivery Order SPE2DB20D1051-SPE2DB24FD8FC
Award Date 5/31/24
Potential Completion Date 6/3/24
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with the ID SPE2DB20D1102|SPE2DB25FC5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567073984 - VALSARTAN-HCTZ 320-25 MG TAB 90S, with a ceiling value of $3,030.79 and a performance period ending on January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,644.01, is a Firm Fixed Price Delivery Order for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This contract award, with ID SPE2DB20D3303|SPE2DB25FZ4E1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.24, is for the delivery of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award, with identification number SPE2DB20D3101|SPE2DB24FQYS3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $3,591.83 for the provision of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2024 and utilizes a Firm Fixed Price pricing type. It is not designated with any...
- This federal contract award, valued at $1,241.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a prescription medication, with an ultimate completion date of July 17, 2025. The contract is a delivery order with firm fixed pricing and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, identified as SPE2DB22D1106|SPE2DB25FDMP9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $22,579.18, is for the delivery of 4566517497 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 22, 2024. This award is not designated as a Set-Aside contract....
- This federal contract award, valued at $5,893.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of January 13, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award, with ID SPE2DB20D3101 and SPE2DB24FRGV1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,001.48 firm fixed-price delivery order is for 4,564,313,703 units of the pharmaceutical product Valsartan-HCTZ 160-12.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FG2FD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,464.33 firm fixed-price delivery order is for the supply of 4568202294 VALSARTAN-HCTZ 160-25 MG TAB 90S, with a performance period through May 12, 2025. The contract is not set-aside and allows for the provision of a wide range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S. The $8,953.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...